Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 501-510 of 1761 for cancer

Edit search filters
  1. A Safety To Evaluate The Safety And Effectiveness Of Pressurized Intraperitoneal Aerosolized Chemotherapy In Ovarian, Uterine, Colorectal, And Gastric Cancer Patients

    Jacksonville, FL

  2. A Study Of CGM In GBM

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Tebentafusp Regimen Versus Investigator's Choice In Previously Treated Advanced Melanoma (TEBE-AM)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Gemcitabine And Cisplatin As Neoadjuvant Chemotherapy In Patients With High-Grade Upper Tract Urothelial Carcinoma

    Scottsdale/Phoenix, AZ

  5. A Study Of WVT078 In Patients With Multiple Myeloma

    Rochester, MN

  6. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Fruquintinib In Patients With Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. STIMULUS MDS-US : Sabatolimab Added To HMA In Higher Risk MDS

    Scottsdale/Phoenix, AZ

  8. A Study To Compare Treatment With The Drug Selumetinib Alone Versus Selumetinib And Vinblastine In Patients With Recurrent Or Progressive Low-Grade Glioma

    Rochester, MN

  9. Short-course Radiation Therapy For Hepatocellular Carcinoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Trial Of RAdium-223 And SABR Versus SABR For OligomEtastatic Prostate CaNcerS (RAVENS)

    Rochester, MN

.

Mayo Clinic Footer